Overall, this work highlights the clinical potential of GC-PDCOs to guide personalized therapy, predict treatment response, and uncover mechanisms of resistancebridging the gap between bench research and bedside decision-making in precision oncology
Takes about 510 minutes
doi: 10.1038/nrneph.2017.59 138 LaiYZhaoZZengTLiangXChenDDuanXet al
who are we?We are based in Guangdong, China, start from 1993,sell to Mid East,Africa,North America,South America,Southeast Asia,Central America,Northern Europe,Southern Europe
This holistic and collaborative approach helps optimize your results, ensuring that you achieve sustainable, long-term weight loss success with personalized support every step of the way
Thyroid hormone-related regulation of gene expression in human fatty liver